NTRK1 and astrocytoma (excluding glioblastoma): Interleukin-13 Receptor α2, Fos-Related Antigen 1, and EphA2 receptor tyrosine kinase are considered as astrocytoma-associated antigens (AAAs) and potential therapeutic targets [7]-[14].